Introduced
El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.
| By: Schoolcraft | H.B. No. 1319 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to wholesale importation of prescription drugs in this | |
| state. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION1. Subtitle A, Title 6, Chapter 444 Health and Safety Code, | |
| is amended as follows: | |
| CHAPTER 444. WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM | |
| Sec. 444.001. DEFINITIONS. In this chapter: | |
| (1) "Canadian supplier" means a manufacturer, | |
| wholesale distributor, or pharmacy that is appropriately licensed | |
| or permitted under Canadian federal or provincial laws and rules to | |
| manufacture, distribute, or dispense prescription drugs. | |
| (2) "European Union supplier" " means a manufacturer, | |
| wholesale distributor, or pharmacy that is appropriately licensed | |
| or permitted under European Union or laws and rules, or the national | |
| laws and rules of a European Union member nation, to manufacture, | |
| distribute, or dispense prescription drugs. | |
| ( |
|
| Commission. | |
| ( |
|
| licensed as a wholesale distributor under Subchapter N, Chapter | |
| 431, that contracts with this state to import prescription drugs | |
| under the program. | |
| ( |
|
| importation program established under this chapter. | |
| Sec. 444.002. ESTABLISHMENT OF WHOLESALE PRESCRIPTION DRUG | |
| IMPORTATION PROGRAM. (a) The commission shall establish the | |
| wholesale prescription drug importation program to provide lower | |
| cost prescription drugs available outside of the United States to | |
| consumers in this state at the lower cost. | |
| (b) The commission shall implement the program by: | |
| (1) contracting with one or more prescription drug | |
| wholesalers and Canadian or European Union suppliers to import | |
| prescription drugs and provide prescription drug cost savings to | |
| consumers in this state; | |
| (2) developing a registration process for health | |
| benefit plan issuers, health care providers, and pharmacies to | |
| obtain and dispense prescription drugs imported under the program; | |
| (3) developing a list of prescription drugs, including | |
| the prices of those drugs, that meet the requirements of Section | |
| 444.003 and publishing the list on the commission's Internet | |
| website; | |
| (4) establishing an outreach and marketing plan to | |
| generate program awareness; | |
| (5) establishing and administering a telephone call | |
| center or electronic portal to provide information about the | |
| program; | |
| (6) ensuring the program and the prescription drug | |
| wholesalers that contract with this state under Subdivision (1) | |
| comply with the tracking, tracing, verification, and | |
| identification requirements of 21 U.S.C. Section 360eee-1; | |
| (7) prohibiting the distribution, dispensing, or sale | |
| of prescription drugs imported under this chapter outside the | |
| boundaries of this state; and | |
| (8) performing any other duties the executive | |
| commissioner determines necessary to implement the program. | |
| (c) The commission shall ensure that the program meets the | |
| requirements of 21 U.S.C. Section 384. | |
| (d) In developing the program, the commission may consult | |
| with interested parties. | |
| Sec. 444.003. ELIGIBLE PRESCRIPTION DRUGS. A prescription | |
| drug may be imported into this state under the program only if the | |
| drug: | |
| (1) meets the United States Food and Drug | |
| Administration's standards related to prescription drug safety, | |
| effectiveness, misbranding, and adulteration; | |
| (2) does not violate any federal patent laws through | |
| its importation; | |
| (3) is expected to generate cost savings for | |
| consumers; and | |
| (4) is not: | |
| (A) listed as a controlled substance under state | |
| or federal law; | |
| (B) a biological product; | |
| (C) an infused drug; | |
| (D) an intravenously injected drug; | |
| (E) a drug that is inhaled during surgery; or | |
| (F) a parenteral drug. | |
| Sec. 444.004. ANTICOMPETITIVE BEHAVIOR MONITORING. The | |
| commission, in consultation with the attorney general, shall | |
| identify and monitor any potential anticompetitive activities in | |
| industries affected by the program. | |
| Sec. 444.005. PROGRAM FUNDING. In addition to money | |
| appropriated by the legislature, the commission may impose a fee on | |
| each prescription drug sold under the program or establish another | |
| funding method to administer the program. | |
| Sec. 444.006. AUDIT PROCEDURES. The executive commissioner | |
| by rule shall develop procedures to effectively audit a | |
| prescription drug wholesaler participating in the program. | |
| Sec. 444.007. ANNUAL REPORTING. Not later than December 1 | |
| of each year, the commission shall submit a report to the governor | |
| and the legislature regarding the operation of the program during | |
| the preceding state fiscal year, including: | |
| (1) which prescription drugs and Canadian or European | |
| Union suppliers are included in the program; | |
| (2) the number of health benefit plan issuers, health | |
| care providers, and pharmacies participating in the program; | |
| (3) the number of prescriptions dispensed through the | |
| program; | |
| (4) the estimated cost savings to consumers, health | |
| plans, employers, and this state since the establishment of the | |
| program and during the preceding state fiscal year; | |
| (5) information regarding the implementation of the | |
| audit procedures under Section 444.006; and | |
| (6) any other information: | |
| (A) the governor or the legislature requests; or | |
| (B) the commission considers necessary. | |
| SECTION 3. This Act takes effect September 1, 2025. |
Texto oficial de la Legislatura de Texas. El formato se adaptó para leerlo en Ratifi.